February – XLerateHealth (XLH) and academic lead, University of Kentucky (UK), were awarded Phase II of an STTR grant by the National Institutes of Health (NIH) through the IDeA Regional
Entrepreneurship Development (I-RED) Program. With this award, XLH and UK will build on prior work and launch and validate new entrepreneurship education and training tools that foster the translation of promising biomedical discoveries and technologies from research laboratories into
commercial products. (Total Phase I & II award: $3.25M and runs through February 2025.)
April - XLH partnered with ScholarRx, a medical education technology company, to launch a suite of
experience-based entrepreneurship education products and tools supporting the NIH/NIGMS I-RED program.
May - XLH received its 6th Growth Accelerator Fund Competition (GAFC) award! This most recent award
will enable XLH to expand its partnerships in the Southeast IDeA State region, with a goal of
creating equitable access to the innovation ecosystem for STEM/R&D-focused rural
entrepreneurs and innovators at Historically Black Colleges and Universities (HBCUs).
July - 8 startups were accepted into the 2023 XLerateHealth Flagship Accelerator Bootcamp.
September - XLH was selected by the SBA as a Stage Two GAFC Catalyze awardee. This 7th SBA GAFC award will enable XLH to expand its current work, programming, and services in the Southeast IDeA State region to further build this historically underserved region’s “Innovation Ecosystem”.
October - 9 innovators across the Southeast “XLerator Network” were selected to participate in
the NIH funded I-RED program. This inaugural cohort are working on technologies that include
diagnostics, manufacturing, medical devices, and therapeutics, and will receive funding to
further the commercialization of their technologies.